Trials
Search / Trial NCT05653596

VR-based Intervention for Cognitive Restoration

Launched by CHUNGNAM NATIONAL UNIVERSITY · Dec 14, 2022

Trial Information

Current as of January 14, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a new way to help women who have been treated for breast cancer improve their thinking and memory skills using virtual reality (VR). The focus is on a nature-based program that aims to restore cognitive function, which can sometimes be affected by chemotherapy. If you are a woman between the ages of 18 and 70 who is currently undergoing chemotherapy for breast cancer and has noticed issues with thinking and daily activities, you might be eligible to participate. To join, you should be able to understand and respond to questionnaires and be willing to sign consent forms.

If you decide to participate, you'll engage in VR activities designed to help improve your cognitive skills in a fun and immersive way. The study is currently recruiting participants, so there is an opportunity to be involved in this innovative approach to care. It's important to note that some people, such as those with severe nausea, certain neurological disorders, or issues that make it hard to use a VR headset, may not be eligible to join. This trial could offer a unique chance to enhance cognitive function while contributing to important research.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Being treated with chemotherapy for breast cancer
  • Having affirmative responses to three questions about cognitive problems and their impact on daily performance
  • Having FACT-Cog scores of 58 or less
  • Having Mini-Cog scores of 3 and higher
  • Having the ability to read, understand or respond to questionnaires and cognitive assessment
  • Being willing to participate and able to provide written informed consent
  • Exclusion Criteria:
  • Having metastatic breast cancer
  • Having Patient Health Questionnaire-2 score of 3 and higher
  • Being diagnosed with neurological disorders such as dementia, multiple sclerosis, or traumatic brain injury
  • Having epilepsy or seizure
  • Having 'quite a bit' or 'extremely' severe level of nausea and vomiting
  • Having visual or hearing impairments
  • Having other problems that prevent them from wearing the VR headset

Trial Officials

Mi Sook Jung, PhD

Principal Investigator

Chungnam National University

About Chungnam National University

Chungnam National University is a prominent academic institution located in South Korea, dedicated to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive resources and expertise to conduct innovative studies aimed at improving healthcare outcomes. With a focus on collaboration and scientific rigor, Chungnam National University fosters partnerships with various stakeholders, including healthcare professionals, researchers, and industry leaders, to explore cutting-edge therapies and interventions. Through its commitment to ethical standards and patient safety, the university plays a vital role in contributing to the global body of medical knowledge and enhancing the quality of life for individuals and communities.

Locations

Daejeon, , Korea, Republic Of

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials